Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of TNS energy Voronezh recommended that dividends be paid for 2022

4/7/23 VRSB

Arctic LNG Line 2 is 80% complete

4/7/23 NVTK

X5 Group opened a distribution center of Chizhika chain in Kazan

4/7/23 FIVE

EL5-Energo reported for 2022 according to RAS

4/7/23 ELFV

Ozon will build a logistics complex in the center of New Moscow

4/7/23 OZON

Ford Motor announced a quarterly dividend

4/7/23 F

Monopoly will buy back Globaltruck shares ₽82.5 per paper

4/7/23 GTRK

PIK sold a large plot in Novorossiysk

4/7/23 PIKK

Positive Technologies will seek to double its business

4/7/23 POSI

Gazprom will build 60 small-scale LNG plants by 2030

4/7/23 GAZP